Page last updated: 2024-11-04
sarpogrelate and Obesity
sarpogrelate has been researched along with Obesity in 2 studies
sarpogrelate: structure given in first source
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Kataoka, H | 1 |
Ariyama, Y | 1 |
Deushi, M | 1 |
Osaka, M | 1 |
Nitta, K | 1 |
Yoshida, M | 1 |
Nonogaki, K | 1 |
Nozue, K | 1 |
Oka, Y | 1 |
Other Studies
2 other studies available for sarpogrelate and Obesity
Article | Year |
---|---|
Inhibitory Effect of Serotonin Antagonist on Leukocyte-Endothelial Interactions In Vivo and In Vitro.
Topics: Animals; Cell Adhesion; Cell Communication; Cell Line; Endothelial Cells; Endothelium, Vascular; Hum | 2016 |
Increased hypothalamic 5-HT2A receptor gene expression and effects of pharmacologic 5-HT2A receptor inactivation in obese Ay mice.
Topics: Adiponectin; Animals; Appetite; Body Weight; Eating; Gene Expression; Hypothalamus; Male; Mice; Mice | 2006 |